FDA Commissioner Marty Makary Resigns Amid Vaping Policy Dispute

In a sudden leadership shift at the Food and Drug Administration, Dr. Marty Makary resigned as commissioner on Tuesday, May 12, 2026. His departure comes after a period of significant internal tension and mounting pressure regarding the agency’s regulatory decisions, most notably concerning the authorization of flavored e-cigarettes.

President Donald Trump addressed the resignation on Tuesday afternoon, describing Makary as a “great doctor” and a “friend.” While acknowledging that Makary had been “having some difficulty,” the President expressed optimism for his future, stating, “He’s going to go on, and he’s going to do well.”

The Catalyst: The Fruit-Flavored Vape Controversy

The immediate driver behind Makary’s resignation appears to be a fundamental disagreement over the FDA’s stance on flavored vaping products. According to sources close to Health and Human Services leadership, Makary opposed the decision to authorize fruit-flavored vapes for adults, a move that ultimately triggered his exit. Rather than publicly defending a policy he did not support during scheduled congressional testimony on Wednesday, Makary chose to step down.

The regulatory shift follows intense pressure from the vaping industry and the White House. Last Tuesday, the FDA announced it had authorized fruit-flavored vapes for adults in the United States. This follows a May 6 announcement where the agency approved certain flavored e-cigarettes from the company Glas Inc. While the agency touted safety restrictions intended to limit use among young people, the move has remained a flashpoint for controversy.

A Tenure Defined by Internal Tension

Dr. Makary, a surgeon and health researcher, led the agency during a period marked by significant upheaval. His tenure was characterized by unexpected drug rejections, staff departures, and ongoing pressure regarding the regulation of abortion pills.

Beyond policy disagreements, Makary’s leadership drew criticism from various stakeholders within the Trump administration’s orbit. His time at the FDA saw complaints from pharmaceutical executives, vaping lobbyists, and anti-abortion activists. These tensions contributed to a perception of a “rocky tenure” as the agency navigated complex political and public health landscapes.

What’s Next for the FDA?

To ensure continuity at the agency, President Trump announced via Truth Social that Kyle Diamantas will step into the role of acting commissioner. Diamantas, who currently serves as the FDA’s top food regulator, is a lawyer and does not hold a medical degree.

Makary’s resignation marks the fourth high-profile departure of a member of the Trump administration this year, highlighting continued shifts within the federal public health infrastructure.

Key Takeaways

• Resignation Date: Dr. Marty Makary resigned as FDA Commissioner on Tuesday, May 12, 2026.
• Primary Conflict: The resignation was reportedly triggered by Makary’s opposition to the authorization of fruit-flavored vapes for adults.
• Acting Leadership: Kyle Diamantas, the agency’s top food regulator, will serve as acting commissioner.
• Tenure Context: Makary’s term was marked by industry pressure, staff departures, and disputes over drug approvals and reproductive health policies.

Frequently Asked Questions

Why did Dr. Marty Makary resign?

While his tenure involved various challenges, sources indicate that Makary resigned due to his opposition to the FDA’s decision to authorize fruit-flavored vapes for adults. He reportedly chose to step down rather than defend the decision during upcoming congressional testimony.

Who is the acting FDA Commissioner?

Kyle Diamantas, a lawyer and the FDA’s top food regulator, has been appointed to serve as the acting commissioner following Makary’s departure.

What was the FDA’s recent decision on vaping?

Following industry and presidential pressure, the FDA authorized fruit-flavored vapes for adults in the U.S. Last week. This included the approval of certain flavored e-cigarettes from Glas Inc. Earlier in May.